Clinical Trial Update: A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating regadenoson administration after an inadequate exercise stress test versus regadenoson alone for myocardial perfusion imaging …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Regadenoson (Lexiscan) (regadenoson)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Coronary Artery Disease (CAD) | Phase 3 | Status: COMPLETED | Results posted: 2016-02-08